Article Details

FDA lifts hold on Bluebird's sickle cell gene therapy | BioPharma Dive

Retrieved on: 2022-12-19 16:40:21

Tags for this article:

Click the tags to see associated articles and topics

FDA lifts hold on Bluebird's sickle cell gene therapy | BioPharma Dive. View article details on HISWAI: https://www.biopharmadive.com/news/bluebird-bio-sickle-cell-fda-lift-hold-gene-therapy/639064/

Excerpt

Bluebird bio can resume enrolling and treating children and adolescents with sickle cell disease after the Food and Drug Administration lifted a ...

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up